2007•China Practical MedicineRequires access

Clinical study of wenxinkeli in treatment of cardiac arrhythmia

Wang Yan-mi

Open publisher page 1 citations

Abstract

Objective To study the antiarrythmia effect and safety of Wenxinkeli for the patients with cardiac arrhythmia.Methods 120 patients with cardiac arrhythmia,randomized divided into two groups,the treating group(n=60)taken Wenxinkeli 9 g tid for 4 weeks,the control group(n=60)taken propafenone 150mg tid for 4 weeks.Then the effect of cardiac arrhythmia,symptoms and adverse effects were observed.Results The total effective rate of the treating group is 83.3%,the total effective rate of the control group is 85%.The antiarrhythmia effects of Wenxinkeli for cardiac arrhythmia were as same as that of propafenone(P0.05),adverse effects were significantly less than that of propafenone(P0.05).Conclusion Wenxinkeli is effective and safe for cardiac arrhythmia.

About this research paper

What this paper is about

Objective To study the antiarrythmia effect and safety of Wenxinkeli for the patients with cardiac arrhythmia.Methods 120 patients with cardiac arrhythmia,randomized divided into two groups,the treating group(n=60)taken Wenxinkeli 9 g tid for 4 weeks,the control group(n=60)taken propafenone 150mg tid for 4 weeks.Then the effect of cardiac arrhythmia,symptoms and adverse effects were observed.Results The total effective rate of the treating group is 83.3%,the total effective rate of the control group is 85%.The antiarrhythmia effects of Wenxinkeli for cardiac arrhythmia were as same as that of propafenone(P0.05),adverse effects were significantly less than that of propafenone(P0.05).Conclusion Wenxinkeli is effective and safe for cardiac arrhythmia.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the antiarrythmia effect and safety of Wenxinkeli for the patients with cardiac arrhythmia.Methods 120 patients with cardiac arrhythmia,randomized divided into two groups,the treating group(n=60)taken Wenxinkeli 9 g tid for 4 weeks,the control group(n=60)taken propafenone 150mg tid for 4 weeks.Then the effect of cardiac arrhythmia,symptoms and adverse effects were observed.Results The total effective rate of the treating group is 83.3%,the total effective rate of the control group is 85%.The antiarrhythmia effects of Wenxinkeli for cardiac arrhythmia were as same as that of propafenone(P0.05),adverse effects were significantly less than that of propafenone(P0.05).Conclusion Wenxinkeli is effective and safe for cardiac arrhythmia.

Key concepts: Propafenone, Medicine, Cardiac arrhythmia, Adverse effect, Cardiology, Internal medicine, Anesthesia, Atrial fibrillation

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study of wenxinkeli in treatment of cardiac arrhythmia — Research Paper | ScholarLens